Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...

Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according ...

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low dise ...

Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 ye ...

Affordable, multipurpose and effective beauty products that are flying just below the radar are one of our favorite topics to ...

Arcutis is a rare topical dermatology player with accelerating launch metrics and continued growth. Read more about the ...

I’ve been using Magic Molecule’s spray for a year as a cleanser replacement and a spot treatment for my flare-ups and ...

A phase 3 trial confirms delgocitinib cream is safe and effective for long-term treatment of chronic hand eczema, maintaining disease control for up to 52 weeks.

Organon (OGN) announced results from an analysis of the Phase 3 ADORING 3 open-label, long-term extension study evaluating VTAMA cream, 1% once ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...

A new survey commissioned by Leo Pharma confirms there’s plenty of room in the market for its chronic hand eczema treatment ...